Sanofi Revenue Per Share from 2010 to 2025

SNY Stock  USD 51.69  0.95  1.87%   
Sanofi ADR Revenue Per Share yearly trend continues to be fairly stable with very little volatility. Revenue Per Share will likely drop to 18.37 in 2025. Revenue Per Share is the amount of revenue generated by Sanofi ADR per share of stock, calculated by dividing total revenue by the average number of shares outstanding. View All Fundamentals
 
Revenue Per Share  
First Reported
2010-12-31
Previous Quarter
33.1
Current Value
18.37
Quarterly Volatility
7.02189222
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Sanofi ADR financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sanofi ADR's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.2 B, Interest Expense of 604.1 M or Selling General Administrative of 10.1 B, as well as many indicators such as Price To Sales Ratio of 3.95, Dividend Yield of 0.0232 or PTB Ratio of 3.41. Sanofi financial statements analysis is a perfect complement when working with Sanofi ADR Valuation or Volatility modules.
  
Check out the analysis of Sanofi ADR Correlation against competitors.
For more information on how to buy Sanofi Stock please use our How to Invest in Sanofi ADR guide.

Latest Sanofi ADR's Revenue Per Share Growth Pattern

Below is the plot of the Revenue Per Share of Sanofi ADR over the last few years. It is the amount of revenue generated by a company per share of stock, calculated by dividing total revenue by the average number of shares outstanding. Sanofi ADR's Revenue Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sanofi ADR's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 19.356510 Years Trend
Slightly volatile
   Revenue Per Share   
       Timeline  

Sanofi Revenue Per Share Regression Statistics

Arithmetic Mean27.20
Geometric Mean25.86
Coefficient Of Variation25.82
Mean Deviation4.62
Median28.61
Standard Deviation7.02
Sample Variance49.31
Range29.4555
R-Value0.55
Mean Square Error37.14
R-Squared0.30
Significance0.03
Slope0.80
Total Sum of Squares739.60

Sanofi Revenue Per Share History

2025 18.37
2024 33.1
2023 36.78
2022 36.26
2021 31.28
2020 29.81
2019 30.11

About Sanofi ADR Financial Statements

Sanofi ADR investors use historical fundamental indicators, such as Sanofi ADR's Revenue Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Sanofi ADR. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Revenue Per Share 33.10  18.37 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Sanofi Stock Analysis

When running Sanofi ADR's price analysis, check to measure Sanofi ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi ADR is operating at the current time. Most of Sanofi ADR's value examination focuses on studying past and present price action to predict the probability of Sanofi ADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi ADR's price. Additionally, you may evaluate how the addition of Sanofi ADR to your portfolios can decrease your overall portfolio volatility.